Breztri Aerosphere 120mdi

Introduction to Breztri Aerosphere 120mdi

Breztri Aerosphere 120mdi is an inhalation aerosol used primarily for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This medication combines three active ingredients to help manage symptoms and improve lung function. Breztri Aerosphere 120mdi is designed to be inhaled directly into the lungs, providing targeted relief.

Composition of Breztri Aerosphere 120mdi

Breztri Aerosphere 120mdi contains a combination of Glycopyrrolate (7.2mcg), Formoterol (5mcg), and Budesonide (160mcg). Glycopyrrolate is a long-acting muscarinic antagonist that helps relax and open air passages in the lungs. Formoterol is a long-acting beta-agonist that works by relaxing muscles in the airways to improve breathing. Budesonide is a corticosteroid that reduces inflammation in the lungs, helping to prevent asthma attacks and improve breathing.

Uses of Breztri Aerosphere 120mdi

• Maintenance treatment of chronic obstructive pulmonary disease (COPD).
• Improves lung function and reduces the frequency of COPD exacerbations.
• Helps manage symptoms such as shortness of breath, wheezing, and coughing.

Side effects of Breztri Aerosphere 120mdi

• Common side effects: headache, sore throat, runny nose, and cough.
• Serious side effects: chest pain, high blood pressure, and allergic reactions.

Precautions of Breztri Aerosphere 120mdi

Before using Breztri Aerosphere 120mdi, inform your doctor if you have any allergies, heart problems, high blood pressure, or a history of seizures. Avoid contact with eyes and rinse your mouth after use to prevent infections. Do not use this medication to treat sudden breathing problems.

How to Take Breztri Aerosphere 120mdi

Use Breztri Aerosphere 120mdi exactly as prescribed by your doctor. It is typically inhaled twice daily, once in the morning and once in the evening. Follow the instructions provided with the inhaler for proper use and maintenance. Do not exceed the recommended dose.

Conclusion of Breztri Aerosphere 120mdi

Breztri Aerosphere 120mdi, manufactured by AstraZeneca, is a combination inhalation aerosol containing Glycopyrrolate, Formoterol, and Budesonide. It belongs to the therapeutic class of respiratory agents and is primarily used for the maintenance treatment of COPD. This medication helps improve lung function and manage symptoms effectively. Always follow your healthcare provider's instructions for optimal results.